CG MedTech Co

CG MedTech Co Financing Cash Flow

The Net Financing Cash Flow of CG MedTech Co (056090.KQ) as of Nov 19, 2026 is 10.42 B KRW. In the previous year, Net Financing Cash Flow was 875.08 M KRW — a change of 1,090.84% (higher).

Financing Cash Flow

10.42 BKRW

YoY

1,090.84%

Last updated:

Net Financing Cash Flow of CG MedTech Co is 2021 10.42 B KRW. Net Financing Cash Flow of CG MedTech Co was 2020 875.08 M KRW. It decreases by 1,090.84% higher compared to the previous year.

The CG MedTech Co Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2014
4.46 B KRW
Jan 1, 2015
43.06 B KRW
Jan 1, 2016
-8.06 B KRW
Jan 1, 2017
15.94 B KRW
Jan 1, 2018
10.03 B KRW
Jan 1, 2019
-4.51 B KRW
Jan 1, 2020
875.08 M KRW
Jan 1, 2021
10.42 B KRW
The CG MedTech Co Financing Cash Flow history
YEARFinancing Cash FlowYoY
10.42 BKRW+1,090.84%
875.08 MKRW-119.38%
-4.51 BKRW-145.03%
10.03 BKRW-37.11%
15.94 BKRW-297.88%
-8.06 BKRW-118.71%
43.06 BKRW+864.66%
4.46 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CG MedTech Co Stock analysis

What does CG MedTech Co do? CG MedTech Co Ltd generates revenue through two primary business segments. The Medical Device Business segment produces and sells spinal fixation devices, micro-invasive medical devices for back pain treatment, fracture treatment devices, and bioabsorbable alloy implants. These products are sold to healthcare providers and hospitals within the orthopaedic surgical market. The Electric Energy Business segment manufactures and markets electricity meters and integrated calorimeters, targeting utility companies and energy management sectors. Both segments operate under the company's established brand presence in their respective industries. The company's revenue streams are derived from direct sales to end-users in the medical and energy sectors. Orthopaedic surgical implants and devices are purchased by hospitals and clinics specializing in orthopaedic care, while electricity meters and calorimeters are bought by utility providers for infrastructure deployment. The firm's product portfolio is designed to meet specific technical requirements within these specialized markets. CG MedTech Co Ltd's business model focuses on manufacturing high-precision medical devices and energy measurement equipment. The Medical Device Business segment serves the healthcare industry with products for spinal and fracture treatments, while the Electric Energy Business segment supports energy management through metering solutions. This dual-segment approach allows the company to serve two distinct but complementary industrial sectors. CG MedTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CG MedTech Co stock

Net Financing Cash Flow of CG MedTech Co is 10.42 B KRW in 2021.

Net Financing Cash Flow of CG MedTech Co changed from 875.08 M KRW to 10.42 B KRW, representing a 1,090.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow CG MedTech Co since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's CG MedTech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — CG MedTech Co

All Key Metrics — CG MedTech Co